The following is an excerpt.
Large-scale genomic sequencing has identified two DNA mutations that appear to drive about 15 percent of brain tumours known as meningiomas, a finding that could lead to the first effective drug treatments for the tumours, report scientists from Dana-Farber Cancer Institute and the Broad Institute.
View the original article here: Genomic Sequencing Reveals Mutant ‘Drivers’ of Common Brain Tumour